Cargando…
Development of Anticancer Peptides Using Artificial Intelligence and Combinational Therapy for Cancer Therapeutics
Cancer is a group of diseases causing abnormal cell growth, altering the genome, and invading or spreading to other parts of the body. Among therapeutic peptide drugs, anticancer peptides (ACPs) have been considered to target and kill cancer cells because cancer cells have unique characteristics suc...
Autores principales: | Hwang, Ji Su, Kim, Seok Gi, Shin, Tae Hwan, Jang, Yong Eun, Kwon, Do Hyeon, Lee, Gwang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9147327/ https://www.ncbi.nlm.nih.gov/pubmed/35631583 http://dx.doi.org/10.3390/pharmaceutics14050997 |
Ejemplares similares
-
Cerebrospinal Fluid Metabolome in Parkinson’s Disease and Multiple System Atrophy
por: Kwon, Do Hyeon, et al.
Publicado: (2022) -
MLACP: machine-learning-based prediction of anticancer peptides
por: Manavalan, Balachandran, et al.
Publicado: (2017) -
Analysis of Nanotoxicity with Integrated Omics and Mechanobiology
por: Shin, Tae Hwan, et al.
Publicado: (2021) -
Application of Artificial Intelligence in Discovery and Development of Anticancer and Antidiabetic Therapeutic Agents
por: Alqahtani, Amal
Publicado: (2022) -
Retracted: Application of Artificial Intelligence in Discovery and Development of Anticancer and Antidiabetic Therapeutic Agents
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023)